BURLINGTON, Mass., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the Wedbush Life Sciences Management Access Conference on Wednesday, August 15, 2012 at 9:45 AM ET. The conference will be held August 14-15, 2012 at Le Parker Meridien in New York City.
